Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05802615 · ClinicalTrials.gov registry record · NA
Protective Assets Reinforced With Integrated Care and TechnologY (PARITY) Feasibility Trial
A NA study of Blood Pressure and Maternal Health, sponsored by University of Nebraska.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT05802615: Completed NA study of Blood Pressure and Maternal Health, sponsored by University of Nebraska.
NCT05802615 is a NA study of Blood Pressure and Maternal Health that has completed, run by University of Nebraska. The registered enrollment target is 60 participants, below the 286-participant average among 101 other Blood Pressure trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05802615, a NA study of Blood Pressure and Maternal Health, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will determine the feasibility and acceptability of the Protective Assets Reinforced with Integrated care and TechnologY (PARITY) program, to test the clinical, behavioral, and strength building efficacy of the PARITY program and explore how it achieves its outcomes in pregnant Black women. PARITY is a program that provides community-based doula support, community resources, and a mobile technology platform that reinforces individual strengths (referred to as protective assets) through positive messaging and by promoting wellness.
Primary Outcome
Participant blood pressure (systolic and diastolic) (continuous) as well as blood pressure classifications hypertension (\>140/90); Severe hypertension (\>160/110).
Conditions Studied
Interventions
- OTHER Usual Care
- BEHAVIORAL PARITY
Study Locations (1)
Nebraska
- University of Nebraska Medical Center - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2023-04-06 |
| Est. Completion | 2025-08-06 |
| Phase | NA |
What the finished NCT05802615 record still lists
NCT05802615 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 286-participant average among 101 other Blood Pressure trials with a reported enrollment target (79% lower).
The record links to 2 conditions, with Blood Pressure appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.
NCT05802615 reports a single indexed study location in Nebraska.
Frequently Asked Questions
What is clinical trial NCT05802615 about?
NCT05802615 is a clinical study titled "Protective Assets Reinforced With Integrated Care and TechnologY (PARITY) Feasibility Trial". This study will determine the feasibility and acceptability of the Protective Assets Reinforced with Integrated care and TechnologY (PARITY) program, to test the clinical, behavioral, and strength building efficacy of the PARITY program and explore how it achieves its outcomes in pregnant Black wome...
What is the current status of trial NCT05802615?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2023-04-06. Estimated completion is 2025-08-06.
What conditions does trial NCT05802615 study?
This clinical trial studies the following conditions: Blood Pressure, Maternal Health.
What interventions are being tested in trial NCT05802615?
The interventions under investigation include: Usual Care (OTHER), PARITY (BEHAVIORAL).
Who is sponsoring clinical trial NCT05802615?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05802615 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blood Pressure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05802615's enrollment target sits among peer trials
60 52nd of 101 higher than 48 of 101 other Blood Pressure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Blood Pressure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
The GUARDIAN Trial
RECRUITING · NA
-
The Venous Distension Reflex and Orthostatic Hypertension
RECRUITING · NA
-
Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health
RECRUITING · NA
-
The Effect of Transcutaneous Stimulation on Blood Pressure in Spinal Cord Injury (SCI)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI